Journal of Ophthalmic Inflammation and Infection

Table 6 Cure rate at each study visit (ITT)

From: Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

Treatment	All^a (N)	Day 1		Day 3		Day 7		Day 14
Treatment	All^a (N)	N	%	N	%	N	%	N	%
Nepafenac group	105	2	1.9	22	21.0	53	50.5	75	71.4
Placebo group	105	2	1.9	16	15.2	20	19.0	30	28.6
P value			1.00		0.2822		<0.0001		<0.0001

Test = Chi-square (Fisher’s exact test if N < 5)
^aOne patient missing cure data

Back to article page